We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BOT market cap is 582.8M. The company's latest EPS is AUD -0.0058 and P/E is -63.79.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 4.69M | 7.56M | 6.88M | 2.75M | 3.77M |
| Operating Income | -17.16M | -16.7M | -3.39M | -13.19M | -9.13M |
| Net Income | -17.04M | -16.73M | -3.33M | -13.17M | -9.15M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.2M | 25.31M | 21.95M | 14.04M | 24.84M |
| Total Liabilities | 4.59M | 1.67M | 1.15M | 5.89M | 1.89M |
| Total Equity | 615k | 23.64M | 20.8M | 8.15M | 22.95M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -13.14M | -17.36M | -2.97M | -11.19M | -12.07M |
| Investing | -13k | -151k | -8k | -2.92M | -7.05M |
| Financing | 568k | 37.31M | -126k | -152k | 22.03M |
| Market Cap | 582.8M |
| Price to Earnings Ratio | -63.79 |
| Price to Sales Ratio | 154.17 |
| Price to Cash Ratio | 56.92 |
| Price to Book Ratio | 25.39 |
| Dividend Yield | - |
| Shares Outstanding | 1.58B |
| Average Volume (1 week) | 11.96M |
| Average Volume (1 Month) | 13.48M |
| 52 Week Change | 155.17% |
| 52 Week High | 0.405 |
| 52 Week Low | 0.115 |
| Spread (Intraday) | 0.01 (1.33%) |
| Company Name | Botanix Pharmaceuticals Limited |
| Address |
d2, 661 newcastle street perth, western australia 6007 |
| Website | https://www.botanixpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
